SBI Securities’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
Other funds holding INM
SFCM
SBI Securities's INM Position: Q3 2026 in Review
SBI Securities held its InMed Pharmaceuticals (INM) position steady in Q3 2026 at 30 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #3181.
SBI Securities first reported a position in INM in Q1 2025 and has held it in 7 quarters since. The position peaked at $975 in Q2 2025. 16 funds tracked by Wall St. Rank hold INM as of Q3 2026.
- SBI Securities held 30 shares of InMed Pharmaceuticals worth $408 as of Q3 2026.
- SBI Securities left its InMed Pharmaceuticals share count unchanged in Q3 2026.
- InMed Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3181 holding.
- SBI Securities first reported a position in InMed Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SBI Securities's InMed Pharmaceuticals position peaked at $975 in Q2 2025.
- 16 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.